Stockreport

Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform [Yahoo! Finance]

Xenetic Biosciences, Inc.  (XBIO) 
NASDAQ:AMEX Investor Relations: ir.xeneticbio.com
PDF FRAMINGHAM, MA / ACCESSWIRE / December 16, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing [Read more]